Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Recruiting N/A Interventional Study
Glaucoma, Primary Open Angle
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
80 (estimated)
Sponsor
Wills Eye · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age 18 to 90 years * diagnosis of primary open angle glaucoma (Mild, Moderate and Advanced) * healthy subjects with no eye disease Exclusion Criteria: * Diseases, ophthalmic or systemic, that are likely to affect OCTA results * greater than moderate cataract * nystagmus * in…
Contacts

M. Reza Razeghinejad, MD

215-928-7023

mrazeghi@willseye.org

CONTACT

Jeanne Molineaux, COA

215-825-4713

jmolineaux@gwillseye.org

CONTACT